Immediate Impact

2 by Nobel laureates 4 from Science/Nature 73 standout
Sub-graph 1 of 23

Citing Papers

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
2022 Standout
Chemistries of bifunctional PROTAC degraders
2022 Standout
2 intermediate papers

Works of C. Rocha being referenced

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial
2009
Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial
2009

Author Peers

Author Last Decade Papers Cites
C. Rocha 322 85 77 148 147 9 363
Miklós Dióssy 259 125 56 224 120 11 375
Robin Brenner 271 67 48 104 197 12 350
D. Toppmeyer 285 37 70 112 117 9 371
Elisabeth Breit 208 63 25 84 173 8 308
Stephanie A. Hamilton 253 102 99 127 155 12 402
Ranjan Chrisanthar 169 47 69 174 131 9 317
Daniela Petriella 131 69 52 182 146 13 344
Tabari M. Baker 257 68 59 227 94 12 393
Kathleen A. Bridges 196 69 16 272 52 9 370
Shiaw-Yih Lin 165 45 29 213 89 7 320

All Works

Loading papers...

Rankless by CCL
2026